The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and α2β interferon versus VBMCP: Results of a Phase III Eastern Cooperative Oncology Group Study E5A93

Robert A. Kyle, Susanna Jacobus, William R. Friedenberg, Coenraad Frederik Slabber, S. Vincent Rajkumar, Philip R. Greipp

Research output: Contribution to journalArticle

5 Scopus citations

Fingerprint Dive into the research topics of 'The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and α<sub>2</sub>β interferon versus VBMCP: Results of a Phase III Eastern Cooperative Oncology Group Study E5A93'. Together they form a unique fingerprint.

Medicine & Life Sciences